ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637693 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637693; 2) Community: the network communities that were significantly associated with the response to NSC 637693; 3) Molecule: the relationships between components within communities and NSC 637693; 4) MDR: the compounds that were significantly associated with the NSC 637693.

NSC Compound Enrichment Correlation
NSC 699757 Null 0.0228801759885691 0.33064259
NSC 703544 Null 0.0228801759885691 0.26945219
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0228801759885691 0.16754566
NSC 736802 Null 0.0228801759885691 0.29380323
NSC 747461 Null 0.0228801759885691 0.0040059607
NSC 758881 Orlistat (USAN) 0.0228801759885691 0.24158839
NSC 227279 1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- 0.0238174255956144 0.41192961
NSC 301457 Cycloalkannin 0.0238174255956144 0.3843508
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0238174255956144 0.3873651
NSC 762611 Null 0.0238174255956144 0.25310921
Total:64  Current:31    [First] [Prev] [Next] [Last]